PRISMCORE
pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of genetic diseases and disorders, genomic diseases and disorders, and cancer; gene and cell therapy products, namely, monoclonal antibodies, bi-specifics antibodies, chimeric antigen receptors, and synthetic receptor proteins, pharmaceuticals, and pharmaceutical preparations developed with a computational platform engine using biology and chemistry analytics for the treatment of genetic diseases and disorders, geno...
Pending · March 7, 2023 · 97826210 ·